Episurf Medical AB (publ) (STO:EPIS.B)

Episurf Medical AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Revenue	20.2	20.6	19.8	6.6	6.5
Revenue	20.2	20.6	19.8	6.6	6.5
Revenue Growth (YoY)	-1.94%	4.04%	200.00%	1.54%	30.00%
Cost of Revenue	10.1	52.4	61.6	36.2	35
Gross Profit	10.1	-31.8	-41.8	-29.6	-28.5
Selling, General & Admin	30.9	36.5	46.6	40.3	34
Other Operating Expenses	28.9	-0.1	-0.3	-0.3	-0.4
Operating Expenses	67.9	45.4	55	47.4	41
Operating Income	-57.8	-77.2	-96.8	-77	-69.5
Interest Expense	-0.6	-1	-0.9	-0.7	-0.2
Interest & Investment Income	0.5	2.2	3.1	0.5	0.4
Other Non Operating Income (Expenses)	-	0.1	0.1	-	-0.1
EBT Excluding Unusual Items	-57.9	-75.9	-94.5	-77.2	-69.4
Other Unusual Items	-	-	-	-	0.1
Pretax Income	-57.9	-75.9	-94.5	-77.2	-69.3
Income Tax Expense	0.3	0.1	0.3	0.1	-
Net Income	-58.2	-76	-94.8	-77.3	-69.3
Net Income to Common	-58.2	-76	-94.8	-77.3	-69.3
Shares Outstanding (Basic)	987	495	314	267	227
Shares Outstanding (Diluted)	987	495	314	267	227
Shares Change (YoY)	99.37%	57.49%	17.84%	17.67%	39.80%
EPS (Basic)	-0.06	-0.15	-0.30	-0.29	-0.31
EPS (Diluted)	-0.06	-0.15	-0.30	-0.29	-0.31
Free Cash Flow	-55.3	-71.4	-84.8	-69.5	-59.8
Free Cash Flow Per Share	-0.06	-0.14	-0.27	-0.26	-0.26
Gross Margin	50.00%	-154.37%	-211.11%	-	-
Operating Margin	-286.14%	-374.76%	-488.89%	-1166.67%	-1069.23%
Profit Margin	-288.12%	-368.93%	-478.79%	-1171.21%	-1066.15%
Free Cash Flow Margin	-273.76%	-346.60%	-428.28%	-1053.03%	-920.00%
EBITDA	-52.2	-74.1	-94.1	-74.4	-66.6
EBITDA Margin	-258.42%	-	-	-	-
D&A For EBITDA	5.6	3.1	2.7	2.6	2.9
EBIT	-57.8	-77.2	-96.8	-77	-69.5
EBIT Margin	-286.14%	-	-	-	-
Revenue as Reported	22.8	20.7	20.1	18.2	13.8

Source: S&P Global Market Intelligence. Standard template. Financial Sources.